Pituitary

, Volume 18, Issue 3, pp 306–311 | Cite as

KISS1 receptor is preferentially expressed in clinically non-functioning pituitary tumors

  • Marianna Yaron
  • Ulrich Renner
  • Suzan Gilad
  • Günter K. Stalla
  • Naftali Stern
  • Yona Greenman
Article
First Online:

Abstract

Objective

KISS1 is a metastasis suppressor gene involved in cancer biology. Given the high expression levels of KISS1 and KISS1R in the hypothalamus and the pituitary respectively, we hypothesized that this system could possibly affect tumor invasiveness and clinical behavior of pituitary tumors.

Methods

Expression levels of KISS1 and KISS1R mRNA were evaluated by RT-PCR. Clinical information pertaining tumor characteristics was extracted from patients’ charts.

Results

Tumors from 39 patients (21 females, mean age 47.5 years) were examined. KISS1R was expressed in 26 (67 %) of samples (94 % of NFPA, 42 % of GH-, 67 % of ACTH-, and 25 % of PRL-secreting adenomas) and was found more often in female patients (81 vs. 50 % males, p < 0.05); and in NFPA (94 vs. 45.5 % in secreting tumors; p = 0.003). Patients expressing KISS1R were older at presentation (50.5 ± 1.4 vs. 38.1 ± 1.3 years; p = 0.008). In the multivariate analysis, factors significantly associated with KISS1R expression included female gender (OR 13.8, 95 % CI 1.22–155.9; p = 0.03) and having a NFPA (OR 24.7, 95 % CI 1.50–406.4; p = 0.02). Tumor size, invasiveness and age at presentation were not independently associated with KISS1R expression. Pituitary tumors and normal pituitary were negative for KISS1 mRNA expression.

Conclusions

The majority of human NFPA expressed KISS1R with lower rates of expression in other types of pituitary tumors. KISS1R expression did not impart a clinical beneficial tumor phenotype, as it was not associated with tumor size or invasiveness. Additional studies are required to elucidate the role of KISS1 receptor in pituitary gland physiology and pathology.

Keywords

KISS1 GPR54 KISS1R Pituitary adenoma 

Abbreviations

NFPA

Non functional pituitary adenoma

KISS1R

KISS1 receptor

GH

Growth hormone

ACTH

Adrenocorticotropic hormone

PRL

Prolactin

This is a preview of subscription content, log in to check access.

Notes

Conflict of interest

The authors have no disclosures to declare and they have no conflict of interest.

Ethical standard

We declare that the experiments comply with the current laws of our country.

Supplementary material

11102_2014_572_MOESM1_ESM.docx (245 kb)
Supplementary material 1 (DOCX 244 kb)

References

  1. 1.
    Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, Welch DR (1996) KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst 88:1731–1737CrossRefPubMedGoogle Scholar
  2. 2.
    Lee JH, Welch DR (1997) Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Res 57:2384–2385PubMedGoogle Scholar
  3. 3.
    Kotani M, Detheux M, Vandenbogaerde A, Communi D, Vanderwinden JM, Le Poul E, Brezillon X, Tyldesley R, Suarez-Huerta N, Vandeput F, Blanpain C, Schiffmann SN, Vassart G, Parmentier M (2001) The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem 276:34631–34636CrossRefPubMedGoogle Scholar
  4. 4.
    Ohtaki T, Shintani Y, Honda S, Matsumoto H, Hori A, Kanehashi K, Terao Y, Kumano S, Takatsu Y, Masuda Y, Ishibashi Y, Watanabe T, Asada M, Yamada T, Suenaga M, Kitada C, Usuki S, Kurokawa T, Onda H, Nishimura O, Fujino M (2001) Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein coupled receptor. Nature 411:613–617CrossRefPubMedGoogle Scholar
  5. 5.
    Muir AL, Chamberlain L, Eshourbagy NA, Michalovich D, Moore DJ, Calamari A, Szekeres PG, Sarau HM, Chambers JK, Murdock P, Steplewski K, Shabon U, Miller JE, Middleton SE, Darker JG, Larminie CGC, Wilson S, Bergsma DJ, Emson P, Faull R, Philpott KL, Harrison DC (2001) AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem 276:28969–28975CrossRefPubMedGoogle Scholar
  6. 6.
    Lee DK, Nguyen T, O’Neill GP, Cheng R, Liu Y, Howard AD, Coulombe N, Tan CP, Tang-Nguyen AT, George SR, O’Dowd BF (1999) Discovery of a receptor related to the galanin receptors. FEBS Lett 446:103–107CrossRefPubMedGoogle Scholar
  7. 7.
    Shirasaki F, Takata M, Hatta N, Takehara K (2001) Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23. Cancer Res 61:7422–7425PubMedGoogle Scholar
  8. 8.
    Dhar DK, Naora H, Kubota H, Maruyama R, Yoshimura H, Tonomoto Y, Tachibana M, Ono T, Otani H, Nagasue N (2004) Downregulation of KISS-1 expression is responsible for tumor invasion and worse prognosis in gastric carcinoma. Int J Cancer 111:868–872CrossRefPubMedGoogle Scholar
  9. 9.
    Ikeguchi M, Yamaguchi K, Kaibara N (2004) Clinical significance of the loss of KiSS1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in esophageal squamous cell carcinoma. Clin Cancer Res 10:1379–1383CrossRefPubMedGoogle Scholar
  10. 10.
    Sanches-Carbayo M, Capodieci P, Cordon-Cardo C (2003) Tumor suppressor role of KiSS-1 in bladder cancer: loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome. Am J Pathol 162:609–617CrossRefGoogle Scholar
  11. 11.
    Ringel MD, Hardy E, Bernet VJ, Burch HB, Schuppert F, Burman KD, Saji M (2002) Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells. JCEM 87:2399PubMedGoogle Scholar
  12. 12.
    Nagai K, Doi R, Katagiri F, Ito T, Kida A, Koizumi M, Masui T, Kawaguchi Y, Tomita K, Oishi S, Fujii N, Uemoto S (2009) Prognostic value of metastin expression in human pancreatic cancer. J Exp Clin Cancer Res 21:28–29Google Scholar
  13. 13.
    Hata K, Dhar DK, Watanabe Y, Nakai H, Hoshiai H (2007) Expression of metastin and a G-protein-coupled receptor (AXOR12) in epithelial ovarian cancer. Eur J Cancer 43:1452–1459CrossRefPubMedGoogle Scholar
  14. 14.
    Ikeguchi M, Hirooka Y, Kaibara N (2003) Quantitative reverse transcriptase polymerase chain reaction analysis for KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in hepatocellular carcinoma. J Cancer Res Clin Oncol 129:531–535CrossRefPubMedGoogle Scholar
  15. 15.
    Martin TA, Watkins G, Jiang WG (2005) KiSS-1 expression in human breast cancer. Clin Exp Metastasis 22:503–511CrossRefPubMedGoogle Scholar
  16. 16.
    Makri A, Pissimissis N, Lembessis P, Polychronakos C, Koutsilieris M (2008) The kisspeptin (KiSS-1)/GPR54 system in cancer biology. Cancer Treat Rev 8:682–692CrossRefGoogle Scholar
  17. 17.
    Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS Jr, Shagoury JK, Bo-Abbas Y, Kuohung W, Schwinof KM, Hendrick AG, Zahn D, Dixon J, Kaiser UB, Slaugenhaupt SA, Gusella JF, O’Rahilly S, Carlton MB, Crowley WF Jr, Aparicio SA, Colledge WH (2003) The GPR54 gene as a regulator of puberty. N Engl J Med 349:1614–1627CrossRefPubMedGoogle Scholar
  18. 18.
    Seminara SB (2005) Metastin and its G protein-coupled receptor, GPR54: critical pathway modulating GnRH secretion. Front Neuroendocrinol 26:131–138CrossRefPubMedGoogle Scholar
  19. 19.
    de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E (2003) Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci USA 100:10972–10976CrossRefPubMedCentralPubMedGoogle Scholar
  20. 20.
    Teles MG, Bianco SD, Brito VN, Trarbach EB, Kuohung W, Xu S, Seminara SB, Mendonca BB, Kaiser UB, Latronico AC (2008) A GPR54-activating mutation in a patient with central precocious puberty. N Engl J Med 358:709–715CrossRefPubMedCentralPubMedGoogle Scholar
  21. 21.
    Silveira LG, Noel SD, Silveira-Neto AP, Abreu AP, Brito VN, Santos MG, Bianco SD, Kuohung W, Xu S, Gryngarten M, Escobar ME, Arnhold IJ, Mendonca BB, Kaiser UB, Latronico AC (2010) Mutations of the KISS1 gene in disorders of puberty. JCEM 95:2276–2280PubMedCentralPubMedGoogle Scholar
  22. 22.
    Pinilla L, Aguilar E, Dieguez C, Millar RP, Tena-Sempere M (2012) Kisspeptins and reproduction: physiological roles and regulatory mechanisms. Physiol Rev 92:1235–1316CrossRefPubMedGoogle Scholar
  23. 23.
    Richard N, Galmiche G, Corvaisier S, Caraty A, Kottler ML (2008) KiSS-1 and GPR54 genes are co-expressed in rat gonadotrophs and differentially regulated in vivo by oestradiol and gonadotrophin-releasing hormone. J Neuroendocrinol 3:381–393CrossRefGoogle Scholar
  24. 24.
    Gutiérrez-Pascual E, Martínez-Fuentes AJ, Pinilla L, Tena-Sempere M, Malagón MM, Castaño JP (2007) Direct pituitary effects of kisspeptin: activation of gonadotrophs and somatotrophs and stimulation of luteinising hormone and growth hormone secretion. J Neuroendocrinol 19:521–530CrossRefPubMedGoogle Scholar
  25. 25.
    Navarro VM, Castellano JM, Fernández-Fernández R, Tovar S, Roa J, Mayen A, Nogueiras R, Vazquez MJ, Barreiro ML, Magni P, Aguilar E, Dieguez C, Pinilla L, Tena-Sempere M (2005) Characterization of the potent luteinizing hormone-releasing activity of KiSS-1 peptide, the natural ligand of GPR54. Endocrinology 146:156–163CrossRefPubMedGoogle Scholar
  26. 26.
    Luque RM, Córdoba-Chacón J, Gahete MD, Navarro VM, Tena-Sempere M, Kineman RD, Castaño JP (2011) Kisspeptin regulates gonadotroph and somatotroph function in nonhuman primate pituitary via common and distinct signaling mechanisms. Endocrinology 152:957–966CrossRefPubMedCentralPubMedGoogle Scholar
  27. 27.
    Martínez-Fuentes AJ, Molina M, Vázquez-Martínez R, Gahete MD, Jiménez-Reina L, Moreno-Fernández J, Benito-López P, Quintero A, de la Riva A, Diéguez C, Soto A, Leal-Cerro A, Resmini E, Webb SM, Zatelli MC, degli Uberti EC, Malagón MM, Luque RM, Castaño JP (2011) Expression of functional KISS1 and KISS1R system is altered in human pituitary adenomas: evidence for apoptotic action of kisspeptin-10. Eur J Endocrinol 164:355–362CrossRefPubMedGoogle Scholar
  28. 28.
    Wilson C (1990) Role of surgery in management of pituitary tumors. Neurosurg Clin N Am 1:139–159PubMedGoogle Scholar
  29. 29.
    Asa SL (1998) Tumors of the pituitary gland. In: Rosai J (eds) Atlas of tumor pathology, 3rd series Fascicle 22, Armed Forces Institute of Pathology, Washington, pp 1–214Google Scholar
  30. 30.
    Yan C, Wang H, Boyd DD (2001) KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-κB binding to the promoter as a consequence of IκBα-induced block of p65/p50 nuclear translocation. J Biol Chem 276:1164–1172CrossRefPubMedGoogle Scholar
  31. 31.
    Kadokawa H, Suzuki S, Hashizume T (2008) Kisspeptin-10 stimulates the secretion of growth hormone and prolactin directly from cultured bovine anterior pituitary cells. Anim Reprod Sci 105:404–408CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Marianna Yaron
    • 1
  • Ulrich Renner
    • 2
  • Suzan Gilad
    • 1
  • Günter K. Stalla
    • 2
  • Naftali Stern
    • 1
  • Yona Greenman
    • 1
  1. 1.Institute of Endocrinology, Metabolism and HypertensionTel Aviv-Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv UniversityTel AvivIsrael
  2. 2.Neuroendocrinology GroupMax-Plank-Institute of PsychiatryMunichGermany

Personalised recommendations